Nothing said here yet.
to join the conversation.
BILLERICA, Mass., October 20, 2026--Bruker Corporation (Nasdaq: BRKR) today announced it will report third quarter 2026 financial results before market opening on Wednesday, November 4, 2026. The Company will host a conference call and webcast at 8:30 a.m.
Bruker (NasdaqGS:BRKR) and Charité have released a draft atlas of the human plasma proteome at proteoform resolution. The project maps more than 179,000 distinct plasma proteoforms, using Bruker's timsTOF mass spectrometry platform as a core technology.
Bruker (BRKR) just rolled out new timsUltra AIP and timsOmni workflows, extending its mass spectrometry platform into deeper protein sequencing, glycopeptide analysis, structural proteomics, and oligonucleotide characterization, which could matter for long…
BRKR shares surge 66.3% in a year, fueled by strong demand in mass spectrometry and biopharma, despite restructuring challenges and currency headwinds.
Investors need to pay close attention to BRKR stock based on the movements in the options market lately.
SINGAPORE, September 28, 2026--At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis.
Bruker (NASDAQ:BRKR) CFO Gerald Herman said the company’s second-quarter results reflected stronger-than-expected organic order bookings and earnings per share, while revenue came in later than anticipated.
Bruker Corporation previously announced a multi-system order worth more than US$6.00 million from the University of California, Berkeley to equip the Pines Magnetic Resonance Center with next-generation high-field NMR instrumentation, including an AV NEO-X 800 MHz spectrometer with a cryogenically cooled MAS CryoProbe and multiple supporting systems, scheduled for delivery in 2027.
BERKELEY, Calif., September 21, 2026--Bruker Corporation (Nasdaq: BRKR) today announced a multi-system order from the University of California, Berkeley for high-field Nuclear Magnetic Resonance (NMR) instrumentation at the Pines Magnetic Resonance Center.
Shares of scientific instrument company Bruker (NASDAQ:BRKR) fell 6.3% in the afternoon session after UBS initiated coverage on the stock with a Neutral rating and a $65 price target.
BILLERICA, Mass., September 08, 2026--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences:
On September 4, Bruker (NASDAQ:BRKR) said its energy and supercon technologies unit, Bruker Energy & Supercon Technologies (or BEST), had struck a supply collaboration with Luvata Materials & Solutions to scale up production of RRP superconductors for magnetic confinement fusion.